TickerFacts.

Sutro Biopharma, Inc. (STRO): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$132.45M
As of 2025-12-31
-$103.32M
As of 2026-06-30
$332.05M2016-12-31: -$90.90M2017-12-31: -$109.00M2018-12-31: $131.54M2019-12-31: $97.79M2020-12-31: $332.05M2021-12-31: $252.56M2022-12-31: $217.05M2023-12-31: $149.65M2024-12-31: $44.60M2025-12-31: -$132.45M-$132.45M
2016-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$132.45Mn/m2026-03-23, Balance as of period end
2024-12-31$44.60M-70.2%2026-03-23, Balance as of period end
2023-12-31$149.65M-31.1%2025-03-13, Balance as of period end
2022-12-31$217.05M-14.1%2025-03-13, Balance as of period end
2021-12-31$252.56M-23.9%2024-03-25, Balance as of period end
2020-12-31$332.05M+239.6%2023-03-30, Balance as of period end
2019-12-31$97.79M-25.7%2023-03-30, Balance as of period end
2018-12-31$131.54Mn/m2021-03-18, Balance as of period end
2017-12-31-$109.00Mn/m2020-03-16, Balance as of period end
2016-12-31-$90.90Mn/a2019-04-01, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Sutro Biopharma, Inc. (STRO)2025-12-31-$132.45Mn/m
Century Therapeutics, Inc. (IPSC)2025-12-31$158.94M-1.5%
ImmunityBio, Inc. (IBRX)2025-12-31-$500.47Mn/m
Agenus Inc (AGEN)2025-12-31-$271.11Mn/m
Atara Biotherapeutics, Inc. (ATRA)2025-12-31-$38.50Mn/m
4D Molecular Therapeutics, Inc. (FDMT)2025-12-31$505.66M-1.0%
Monte Rosa Therapeutics, Inc. (GLUE)2025-12-31$233.06M+4.5%
MeiraGTx Holdings plc (MGTX)2025-12-31-$5.79Mn/m
Autolus Therapeutics plc (AUTL)2025-12-31$178.13M-58.3%

Compare STRO, IPSC, IBRX, AGEN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗